MedTrace Logo

Vitaliti Continuous Vital Signs Monitor User-Testing Protocol: VERDICT-2

NCT06464094 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-06-18

No results posted yet for this study

Summary

The VERDICT-2 user testing study will user test the Cloud DX Vitaliti Continuous Vital Signs Monitor (Model: CVSM-1A) in an ambulatory context with post-surgical participants, their family members (caregiver support role) and clinicians (nurses and physicians) at Hamilton Health Sciences to examine user acceptance and user experiences, while soliciting user feedback on wearability compliance and proposed clinical workflows.

Conditions

  • Surgery

Interventions

OTHER

User-testing of Vitaliti Continuous Vital Sign Monitor Model CVSM-1A

Single group enrollment to examine user-acceptance and user experiences, while soliciting user feedback on wearability compliance (patient) and proposed clinical workflows using the most recent Vitaliti™ CVSM device.

Sponsors & Collaborators

  • McMaster University

    collaborator OTHER

  • Population Health Research Institute

    collaborator OTHER

  • Cloud DX Inc.

    collaborator INDUSTRY

  • Hamilton Health Sciences Corporation

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-30
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06464094 on ClinicalTrials.gov